Michael Lim

36.3k total citations · 8 hit papers
391 papers, 17.2k citations indexed

About

Michael Lim is a scholar working on Genetics, Oncology and Neurology. According to data from OpenAlex, Michael Lim has authored 391 papers receiving a total of 17.2k indexed citations (citations by other indexed papers that have themselves been cited), including 153 papers in Genetics, 127 papers in Oncology and 95 papers in Neurology. Recurrent topics in Michael Lim's work include Glioma Diagnosis and Treatment (152 papers), Cancer Immunotherapy and Biomarkers (83 papers) and Meningioma and schwannoma management (75 papers). Michael Lim is often cited by papers focused on Glioma Diagnosis and Treatment (152 papers), Cancer Immunotherapy and Biomarkers (83 papers) and Meningioma and schwannoma management (75 papers). Michael Lim collaborates with scholars based in United States, Australia and United Kingdom. Michael Lim's co-authors include Chetan Bettegowda, Christopher M. Jackson, Michael Weller, John Choi, Yuanxuan Xia, Charles G. Drake, Jonathan W. Simons, Angelo M. De Marzo, David Zagzag and Peter Buechler and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Michael Lim

374 papers receiving 16.9k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases.

1999 1.9k citations Michael Lim et al. profile →
Current state of immunotherapy for glioblastoma

2018 951 citations Michael Lim, Chetan Bettegowda et al. profile →
Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma

2020 946 citations Michael Lim, Michael Weller et al. profile →
Radiation and checkpoint blockade immunotherapy: radiosensitisation and potential mechanisms of synergy

2015 661 citations Michael Lim, Charles G. Drake et al. profile →
Mechanisms of immunotherapy resistance: lessons from glioblastoma

2019 519 citations Christopher M. Jackson, Michael Lim et al. profile →
Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma

2013 371 citations Jon Weingart, Jaishri O. Blakeley et al. profile →
Nivolumab with or without ipilimumab in patients with recurrent glioblastoma: results from exploratory phase I cohorts of CheckMate 143

2017 362 citations Michael Lim, Timothy F. Cloughesy et al. profile →
Glioma

2024 173 citations Michael Weller, Patrick Y. Wen et al. Nature Reviews Disease Primers profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Lim United States	61	5.4k	5.4k	4.3k	4.3k	3.1k	391	17.2k
James J. Vredenburgh United States	63	4.7k 0.9×	8.2k 1.5×	1.8k 0.4×	4.1k 1.0×	3.6k 1.2×	266	15.2k
Kevin Camphausen United States	63	5.3k 1.0×	3.0k 0.6×	2.5k 0.6×	5.6k 1.3×	3.5k 1.1×	329	14.5k
Mark R. Gilbert United States	77	5.9k 1.1×	15.1k 2.8×	2.4k 0.6×	6.6k 1.5×	6.8k 2.2×	491	24.8k
Allan H. Friedman United States	75	5.6k 1.0×	12.2k 2.3×	3.3k 0.8×	7.2k 1.7×	4.8k 1.5×	345	25.7k
Christine Marosi Austria	46	4.5k 0.8×	14.7k 2.8×	2.4k 0.5×	7.2k 1.7×	5.6k 1.8×	196	24.4k
Howard A. Fine United States	77	5.2k 1.0×	9.6k 1.8×	1.6k 0.4×	9.1k 2.1×	3.8k 1.2×	235	21.3k
Kenneth Aldape United States	90	6.6k 1.2×	11.2k 2.1×	3.3k 0.8×	13.1k 3.0×	4.8k 1.5×	369	27.8k
Haley Gittleman United States	33	2.9k 0.5×	11.7k 2.2×	1.6k 0.4×	6.2k 1.4×	4.3k 1.4×	77	21.1k
Axel Benner Germany	79	6.4k 1.2×	7.5k 1.4×	4.2k 1.0×	9.7k 2.3×	1.9k 0.6×	398	24.1k
Timothy A. Chan United States	77	10.4k 1.9×	2.7k 0.5×	4.5k 1.0×	9.4k 2.2×	5.5k 1.8×	243	22.7k

Countries citing papers authored by Michael Lim

Since Specialization

Citations

This map shows the geographic impact of Michael Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Lim more than expected).

Fields of papers citing papers by Michael Lim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Lim. The network helps show where Michael Lim may publish in the future.

Co-authorship network of co-authors of Michael Lim

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Lim. A scholar is included among the top collaborators of Michael Lim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Lim. Michael Lim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Yedavalli, Vivek, Michael Lim, Christopher M. Jackson, et al.. (2025). Effects of diagnosed depression on postoperative outcomes after microvascular decompression for patients with trigeminal neuralgia. Clinical Neurology and Neurosurgery. 250. 108733–108733.

2.

Medikonda, Ravi, et al.. (2025). The Metabolic Orchestration of Immune Evasion in Glioblastoma: From Molecular Perspectives to Therapeutic Vulnerabilities. Cancers. 17(11). 1881–1881. 13 indexed citations

3.

Yedavalli, Vivek, Michael Lim, Christopher M. Jackson, et al.. (2025). Effects of the length of preoperative conservative management on postoperative outcomes after primary microvascular decompression for trigeminal neuralgia. Journal of neurosurgery. 143(1). 92–99.

4.

Xie, Michael E., Kathleen R. Ran, Vivek Yedavalli, et al.. (2024). External assessment of preoperative scores for predicting outcome after microvascular decompression for trigeminal neuralgia. Journal of neurosurgery. 141(4). 1056–1062. 1 indexed citations

5.

Groot, John Frederick De, Timothy F. Cloughesy, Donald A. Berry, et al.. (2024). Evaluation of VAL-083 in GBM AGILE, a phase 3 registration platform trial for newly diagnosed and recurrent glioblastoma.. Journal of Clinical Oncology. 42(16_suppl). 2005–2005.

6.

Weller, Michael, Patrick Y. Wen, Susan M. Chang, et al.. (2024). Glioma. Nature Reviews Disease Primers. 10(1). 33–33. 173 indexed citations breakdown →

7.

Shah, Pavan P., et al.. (2023). The Tumor Immune Microenvironment in Primary CNS Neoplasms: A Review of Current Knowledge and Therapeutic Approaches. International Journal of Molecular Sciences. 24(3). 2020–2020. 11 indexed citations

8.

Wang, Dorothy, Niranjan Behera, Michael D. Kornberg, et al.. (2023). The role of multiple sclerosis subtype in microvascular decompression outcomes for patients with trigeminal neuralgia. Clinical Neurology and Neurosurgery. 233. 107967–107967.

9.

Medikonda, Ravi, Ayush Pant, & Michael Lim. (2023). Immunotherapy as a New Therapeutic Approach for Brain and Spinal Cord Tumors. Advances in experimental medicine and biology. 1394. 73–84. 6 indexed citations

10.

Wu, Adela, et al.. (2022). Quality of Life and Role of Palliative and Supportive Care for Patients With Brain Metastases and Caregivers: A Review. Frontiers in Neurology. 13. 806344–806344. 13 indexed citations

11.

Lal, Bachchu, Weiqiang Zhou, Yongxin Ma, et al.. (2021). Reprogramming Transcription Factors Oct4 and Sox2 Induce a BRD-Dependent Immunosuppressive Transcriptome in GBM-Propagating Cells. Cancer Research. 81(9). 2457–2469. 49 indexed citations

12.

Jiang, Shanshan, Charles G. Eberhart, Michael Lim, et al.. (2018). Identifying Recurrent Malignant Glioma after Treatment Using Amide Proton Transfer-Weighted MR Imaging: A Validation Study with Image-Guided Stereotactic Biopsy. Clinical Cancer Research. 25(2). 552–561. 114 indexed citations

13.

Zeiler, Steven R., Yuan Qiao, Carlos A. Pardo, Michael Lim, & Bruce A. Wasserman. (2018). Vessel Wall MRI for Targeting Biopsies of Intracranial Vasculitis. American Journal of Neuroradiology. 39(11). 2034–2036. 39 indexed citations

14.

Bloch, Orin, Michael Lim, Michael E. Sughrue, et al.. (2017). Autologous Heat Shock Protein Peptide Vaccination for Newly Diagnosed Glioblastoma: Impact of Peripheral PD-L1 Expression on Response to Therapy. Clinical Cancer Research. 23(14). 3575–3584. 87 indexed citations

15.

Salzberg, Steven L., Florian P. Breitwieser, Anupama Kumar, et al.. (2016). Next-generation sequencing in neuropathologic diagnosis of infections of the nervous system. Neurology Neuroimmunology & Neuroinflammation. 3(4). e251–e251. 121 indexed citations

16.

Jackson, Christopher M., Christina M. Kochel, Christopher J. Nirschl, et al.. (2015). Systemic Tolerance Mediated by Melanoma Brain Tumors Is Reversible by Radiotherapy and Vaccination. Clinical Cancer Research. 22(5). 1161–1172. 54 indexed citations

17.

Herrmann, Andreas, Gregory Cherryholmes, Anne Schroeder, et al.. (2014). TLR9 Is Critical for Glioma Stem Cell Maintenance and Targeting. Cancer Research. 74(18). 5218–5228. 60 indexed citations

18.

Albesiano, Emilia, Meghan B. Davis, Alfred P. See, et al.. (2010). Immunologic Consequences of Signal Transducers and Activators of Transcription 3 Activation in Human Squamous Cell Carcinoma. Cancer Research. 70(16). 6467–6476. 19 indexed citations

19.

Sinclair, John, Michael P. Marks, Ronald Levy, et al.. (2005). Visual Field Preservation After Curative Multi-Modality Treatment of Occipital Lobe Arteriovenous Malformations. Neurosurgery. 57(4). 655–667. 14 indexed citations

20.

Sinclair, John, Michael P. Marks, Ronald Levy, et al.. (2005). Visual Field Preservation After Curative Multi-Modality Treatment of Occipital Lobe Arteriovenous Malformations. Neurosurgery. 57(4). 655–667. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact